Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

In vivo analysis of the state of the human uPA enhancer following stimulation by TPA

Abstract

We have analysed in vivo the −2.0 kb enhancer of the human urokinase-type plasminogen activator (uPA) gene in HepG2 cells, in which gene expression can be induced by phorbol esters. The results reveal that, within the regulatory region, the enhancer, the silencer and the minimal promoter become hypersensitive to deoxyribonuclease I (DNase I) upon induction of transcription. The hypersensitivity of the enhancer can be reversed after removal of the inducer. In vivo footprinting analysis indicates that all the cis-acting elements of the enhancer, previously identified in vitro, are occupied in vivo upon 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulation of HepG2 cells. Micrococcal nuclease (MNase) cleavage of this region fails to reveal discrete nucleosomal boundaries in vivo in close proximity of the enhancer, either before or after stimulation. Furthermore, this region does not lose its nucleosomal configuration after TPA induction of transcription. An approximately 600 bp long region around the enhancer becomes more, but not fully, accessible to restriction endonucleases upon stimulation. A time-course experiment shows that this accessibility reaches a plateau after a 1 h TPA treatment suggesting the persistent presence of nucleosomes. These results indicate that TPA induces the binding of transcription factors to the uPA enhancer without chromatin remodelling of this region.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

uPA:

urokinase-type plasminogen activator

DNase I:

deoxyribonuclease I

TPA:

12-O-tetradecanoyl-phorbol-12-acetate

MNase:

micrococcal nuclease

COM:

cooperation mediator

uCOM:

upstream COM

dCOM:

downstream COM

DMEM:

Dulbecco's modified Eagle's medium

SDS:

sodium dodecyl sulphate

PBS:

phosphate buffered saline

DTT:

dithiotreitol

EDTA:

ethylene diamino tetra acetic acid

BSA:

bovine serum albumin

PMSF:

phenyl methyl sulphonyl fluoride

UV:

ultraviolet

LTS LM-PCR:

linker tag-selection ligation-mediated polymerase chain reaction

OP-Cu:

1, 10-phenantroline-copper

GAPDH:

glyceraldehyde 3-phosphate dehydrogenase

References

  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K. (eds) . 1994 Current Protocols in Molecular Biology. Current Protocols.

  • Berthelsen J, Vanderkerkhove J and Blasi F. . 1996 J. Biol. Chem. 271: 3822–3830.

  • Besser D, Verde P, Nagamine Y and Blasi F. . 1996 Fibrinolysis 10: 214–237.

  • Blasi F. . 1997 Immunol. Today 18: 415–417.

  • Cannio R, Rennie PS and Blasi F. . 1991 Nucl. Acids Res. 19: 2303–2308.

  • Cartwright IL and Elgin, SCR. (eds). 1989 Academic Press, San Diego.

  • D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B and Nagamine Y. . 1997 Gene 201: 179–187.

  • Danø K, Behrendt N, Brunner N, Ellis V, Ploug M and Pyke C. . 1994 Fibrinolysis 8: 189–203.

  • De Cesare D, Palazzolo M and Blasi F. . 1996 Oncogene 13: 2551–2562.

  • De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C and Verde P. . 1995 Oncogene 11: 365–376.

  • Guerrini L, Casalino L, Corti A and Blasi F. . 1996 FEBS Lett. 393: 69–73.

  • Jänicke F, Schmitt M, Hafter R, Hollrieder A, Babic R, Ulm K, Gossner W and Graeff H. . 1990 Fibrinolysis 4: 69–78.

  • Lee JS, Catanzariti L, Hemmings BA, Kiefer B and Nagamine Y. . 1994 Nucl. Acids Res. 22: 569–575.

  • Lee JS, von der Ahe D, Kiefer B and Nagamine Y. . 1993 Nucl. Acids Res. 21: 3365–3372.

  • Li GY, Lin HH, Tu ZJ and Kiang DT. . 1998 Gene 209: 139–147.

  • McPherson CE, Shim E-Y, Friedman DS and Zaret KS. . 1993 Cell 75: 387–398.

  • Nerlov C, De Cesare D, Pergola F, Caracciolo A, Blasi F, Johnsen M and Verde P. . 1992 EMBO J. 11: 4573–4582.

  • Novak U, Cocks BG and Hamilton JA. . 1991 Nucl. Acids Res. 19: 3389–3393.

  • Quivy J-P and Becker PB. . 1996 J. Mol. Biol. 256: 249–263.

  • Quivy J-P and Becker PB. . 1997 Methods 11: 171–179.

  • Rørth P, Nerlov C, Blasi F and Johnsen M. . 1990 Nucl. Acids Res. 18: 5009–5017.

  • Stacey KJ, Fowles LF, Colman MS, Ostrowsky MC and Hume DA. . 1995 Mol. Cell. Biol. 15: 3430–3441.

  • Steger DJ and Workman JL. . 1997 EMBO J. 16: 2463–2472.

  • Tsukiyama T, Becker P and Wu C. . 1994 Nature 367: 525–532.

  • Verde P, Boast S, Franzè A, Robbiati F and Blasi F. . 1988 Nucl. Acids Res. 16: 10699–10716.

  • Verde P, Stoppelli MP, Galeffi P, Di Nocera P and Blasi F. . 1984 Proc. Natl. Acad. Sci. 81: 4727–4731.

  • Verdin EP, Paras JR and Van Lint C. . 1993 EMBO J. 12: 3249–3259.

  • Winter H, Rentrop M, Nischt R and Schweizer J. . 1990 Differentiation 43: 105–114.

Download references

Acknowledgements

We thank Peter Becker and Jean-Pierre Quivy for many helpful suggestions on the LTS LM – PCR procedure. We also thank Drs Michael Bustin, Valerio Orlando and Anna Mondino for critically reading the manuscript. This work was supported by grants from Associazione Italiana Richerche sul Cancro (AIRC) and the Italian Ministry of Education (MURST). II-T was supported by a fellowship of the `Comitato Promotore Telethon' (105/BS). This paper is dedicated to the memory of Odette Tallon and Gianni Crippa.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibañez-Tallon, I., Caretti, G., Blasi, F. et al. In vivo analysis of the state of the human uPA enhancer following stimulation by TPA. Oncogene 18, 2836–2845 (1999). https://doi.org/10.1038/sj.onc.1202644

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202644

Keywords

This article is cited by

Search

Quick links